GATA2 and hyperinsulinemic hypoglycemia, familial, 4: Although allo-HSCT is the only curative therapy for the impaired hematopoietic and lymphoid systems of patients with GATA2 deficiency [93,98,99,100], it represents a therapeutic challenge due to disease-associated comorbidities and clinical heterogeneity.